Stephen Kent to Humans
This is a "connection" page, showing publications Stephen Kent has written about Humans.
Connection Strength
0.170
-
Decay of Fc-dependent antibody functions after mild to moderate COVID-19. Cell Rep Med. 2021 06 15; 2(6):100296.
Score: 0.008
-
Hemagglutinin Functionalized Liposomal Vaccines Enhance Germinal Center and Follicular Helper T Cell Immunity. Adv Healthc Mater. 2021 05; 10(10):e2002142.
Score: 0.007
-
Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19. Nat Commun. 2021 02 19; 12(1):1162.
Score: 0.007
-
Moving the HIV vaccine field forward: concepts of protective immunity. Lancet HIV. 2019 06; 6(6):e406-e410.
Score: 0.007
-
Ageing in patients with chronic HIV infection: impact of hypercoagulation. AIDS Res Ther. 2018 11 24; 15(1):22.
Score: 0.006
-
Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies. Retrovirology. 2018 08 22; 15(1):58.
Score: 0.006
-
Anti-HIV-1 antibody-dependent cellular cytotoxicity: is there more to antibodies than neutralization? Curr Opin HIV AIDS. 2018 03; 13(2):160-166.
Score: 0.006
-
HIV Reactivation after Partial Protection by Neutralizing Antibodies. Trends Immunol. 2018 05; 39(5):359-366.
Score: 0.006
-
Antibody-Dependent Cellular Cytotoxicity Responses to Seasonal Influenza Vaccination in Older Adults. J Infect Dis. 2017 12 27; 217(1):12-23.
Score: 0.006
-
A Role for Fc-Mediated Humoral Immunity in Reducing HIV Transmission Rates between HIV Serodiscordant Heterosexual Couples. EBioMedicine. 2017 12; 26:2-3.
Score: 0.006
-
Antibody-dependent phagocytosis (ADP) responses following trivalent inactivated influenza vaccination of younger and older adults. Vaccine. 2017 11 07; 35(47):6451-6458.
Score: 0.006
-
Partial efficacy of a broadly neutralizing antibody against cell-associated SHIV infection. Sci Transl Med. 2017 Aug 09; 9(402).
Score: 0.006
-
Dimeric Fc? Receptor Enzyme-Linked Immunosorbent Assay To Study HIV-Specific Antibodies: A New Look into Breadth of Fc? Receptor Antibodies Induced by the RV144 Vaccine Trial. J Immunol. 2017 07 15; 199(2):816-826.
Score: 0.006
-
Expanding role for type I Interferons in restricting HIV growth. Immunol Cell Biol. 2017 05; 95(5):417-418.
Score: 0.006
-
Thiol-Reactive Star Polymers Display Enhanced Association with Distinct Human Blood Components. ACS Appl Mater Interfaces. 2017 Apr 12; 9(14):12182-12194.
Score: 0.006
-
Fc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design. Hum Vaccin Immunother. 2017 06 03; 13(6):1-9.
Score: 0.006
-
Antibody-dependent cellular cytotoxicity and influenza virus. Curr Opin Virol. 2017 02; 22:89-96.
Score: 0.006
-
Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay. JCI Insight. 2021 08 23; 6(16).
Score: 0.002
-
Structural basis of biased T cell receptor recognition of an immunodominant HLA-A2 epitope of the SARS-CoV-2 spike protein. J Biol Chem. 2021 09; 297(3):101065.
Score: 0.002
-
SARS-CoV-2-specific CD8+ T-cell responses and TCR signatures in the context of a prominent HLA-A*24:02 allomorph. Immunol Cell Biol. 2021 10; 99(9):990-1000.
Score: 0.002
-
From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases. Acta Biomater. 2021 09 01; 131:16-40.
Score: 0.002
-
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 2021 07; 27(7):1205-1211.
Score: 0.002
-
Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: implications for COVID-19 pathogenesis and consequences. Eur Respir J. 2021 05; 57(5).
Score: 0.002
-
Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice. Proc Natl Acad Sci U S A. 2021 05 11; 118(19).
Score: 0.002
-
Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection. Nat Rev Immunol. 2021 06; 21(6):395-404.
Score: 0.002
-
CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity. Immunity. 2021 05 11; 54(5):1066-1082.e5.
Score: 0.002
-
Systems serology detects functionally distinct coronavirus antibody features in children and elderly. Nat Commun. 2021 04 01; 12(1):2037.
Score: 0.002
-
Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques. Nat Commun. 2021 03 03; 12(1):1403.
Score: 0.002
-
Integrated immune dynamics define correlates of COVID-19 severity and antibody responses. Cell Rep Med. 2021 03 16; 2(3):100208.
Score: 0.002
-
Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models. Nat Rev Immunol. 2020 12; 20(12):727-738.
Score: 0.002
-
Suboptimal SARS-CoV-2-specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype. Proc Natl Acad Sci U S A. 2020 09 29; 117(39):24384-24391.
Score: 0.002
-
Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies. Nat Microbiol. 2020 10; 5(10):1185-1191.
Score: 0.002
-
Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19. Nat Med. 2020 09; 26(9):1428-1434.
Score: 0.002
-
Modulation of the CCR5 Receptor/Ligand Axis by Seminal Plasma and the Utility of In Vitro versus In Vivo Models. J Virol. 2019 06 01; 93(11).
Score: 0.002
-
Knowns and Unknowns of Assaying Antibody-Dependent Cell-Mediated Cytotoxicity Against HIV-1. Front Immunol. 2019; 10:1025.
Score: 0.002
-
Immunological basis for enhanced immunity of nanoparticle vaccines. Expert Rev Vaccines. 2019 03; 18(3):269-280.
Score: 0.002
-
Minimum information reporting in bio-nano experimental literature. Nat Nanotechnol. 2018 09; 13(9):777-785.
Score: 0.002
-
The Multifaceted Nature of Immunoglobulin A and Its Complex Role in HIV. AIDS Res Hum Retroviruses. 2018 09; 34(9):727-738.
Score: 0.002
-
The Rare Anaphylaxis-Associated Fc?RIIa3 Exhibits Distinct Characteristics From the Canonical Fc?RIIa1. Front Immunol. 2018; 9:1809.
Score: 0.002
-
A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA. Nat Commun. 2018 07 10; 9(1):2669.
Score: 0.002
-
Contribution of NK Cell Education to both Direct and Anti-HIV-1 Antibody-Dependent NK Cell Functions. J Virol. 2018 06 01; 92(11).
Score: 0.002
-
Identification of Native and Posttranslationally Modified HLA-B*57:01-Restricted HIV Envelope Derived Epitopes Using Immunoproteomics. Proteomics. 2018 06; 18(12):e1700253.
Score: 0.002
-
The effect of antiretroviral intensification with dolutegravir on residual virus replication in HIV-infected individuals: a randomised, placebo-controlled, double-blind trial. Lancet HIV. 2018 05; 5(5):e221-e230.
Score: 0.002
-
Neutrophils mediate HIV-specific antibody-dependent phagocytosis and ADCC. J Immunol Methods. 2018 06; 457:41-52.
Score: 0.002
-
Circulating TFH cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunity. Sci Transl Med. 2018 02 14; 10(428).
Score: 0.002
-
2017 international meeting of the Global Virus Network. Antiviral Res. 2018 05; 153:60-69.
Score: 0.002
-
Modeling of Antilatency Treatment in HIV: What Is the Optimal Duration of Antiretroviral Therapy-Free HIV Remission? J Virol. 2017 12 15; 91(24).
Score: 0.001
-
Exploration of broadly neutralizing antibody fragments produced in bacteria for the control of HIV. Hum Vaccin Immunother. 2017 11 02; 13(11):2726-2737.
Score: 0.001
-
Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome. AIDS. 2017 08 24; 31(13):1839-1845.
Score: 0.001
-
Effect of Combination Antiretroviral Therapy on HIV-1-specific Antibody-Dependent Cellular Cytotoxicity Responses in Subtype B- and Subtype C-Infected Cohorts. J Acquir Immune Defic Syndr. 2017 07 01; 75(3):345-353.
Score: 0.001
-
Relationship between Measures of HIV Reactivation and Decline of the Latent Reservoir under Latency-Reversing Agents. J Virol. 2017 05 01; 91(9).
Score: 0.001
-
Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection. EBioMedicine. 2017 May; 19:119-127.
Score: 0.001
-
Immunological Principles Guiding the Rational Design of Particles for Vaccine Delivery. ACS Nano. 2017 01 24; 11(1):54-68.
Score: 0.001
-
Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field. Curr HIV Res. 2017; 15(3):202-215.
Score: 0.001
-
Recombinant influenza virus expressing HIV-1 p24 capsid protein induces mucosal HIV-specific CD8 T-cell responses. Vaccine. 2016 Feb 24; 34(9):1172-9.
Score: 0.001
-
Antibodies targeting Clec9A promote strong humoral immunity without adjuvant in mice and non-human primates. Eur J Immunol. 2015 Mar; 45(3):854-64.
Score: 0.001